Inventor · disambiguated record
Daniel Hirschhorn-Cymerman
Also filed as: HIRSCHHORN-CYMERMAN DANIEL
8 granted patents·10 pending applications·42 citations·filing 2016–2022
86Inventor score
Files withAGENUS INC18
Top patents by PatentIndex Score
18 records- 0197US10836830B2Antibodies and methods of use thereofAGENUS INC·Filed 2020·Granted Nov 17, 2020·12 cites·45 claims
- 0296US10626181B2Nucleic acids encoding anti-OX40 antibodiesAGENUS INC·Filed 2019·Granted Apr 21, 2020·7 cites·35 claims
- 0395US10259882B2Anti-OX40 antibodiesAGENUS INC·Filed 2016·Granted Apr 16, 2019·16 cites·47 claims
- 0485US11472883B2Methods of administering anti-OX40 antibodiesAGENUS INC·Filed 2020·Granted Oct 18, 2022·1 cites·15 claims
- 0585US11332536B2Vectors comprising nucleic acids encoding anti-OX40 antibodiesAGENUS INC·Filed 2020·Granted May 17, 2022·1 cites·22 claims
- 0684US11447557B2Antibodies and methods of use thereofAGENUS INC·Filed 2016·Granted Sep 20, 2022·3 cites·46 claims
- 0784US11136404B2Anti-OX40 antibodiesAGENUS INC·Filed 2019·Granted Oct 5, 2021·1 cites·64 claims
- 0884US2023167186A1Methods of administering anti-ox40 antibodiesAGENUS INC·Filed 2022·Application pending·0 cites
- 0984US2023108348A1Methods of administering anti-ox40 antibodiesAGENUS INC·Filed 2022·Application pending·0 cites
- 1080US11359028B2Anti-OX40 antibodies and anti-GITR antibodiesAGENUS INC·Filed 2019·Granted Jun 14, 2022·1 cites·16 claims
- 1180US2023406946A1Antibodies and methods of use thereofAGENUS INC·Filed 2022·Application pending·0 cites
- 1280US2023399413A1Antibodies and methods of use thereofAGENUS INC·Filed 2022·Application pending·0 cites
- 1379US2022098316A1Anti-ox40 antibodies and methods of use thereofAGENUS INC·Filed 2021·Application pending·0 cites
- 1473US2022389107A1Anti-ox40 antibodies, anti-gitr antibodies, and methods of use thereofAGENUS INC·Filed 2022·Application pending·0 cites
- 1573US2022380479A1Anti-ox40 antibodies, anti-gitr antibodies, and methods of use thereofAGENUS INC·Filed 2022·Application pending·0 cites
- 1672US2021171648A1Antibodies and methods of use thereofAGENUS INC·Filed 2020·Application pending·0 cites
- 1767US2021324097A1Anti-ox40 antibodies and methods of use thereofAGENUS INC·Filed 2021·Application pending·0 cites
- 1855US2020079862A1Anti-ox40 antibodies and methods of use thereofAGENUS INC·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →